Оne-way sensitivity analysis /Tornado diagram/ of treatment costs for tyrosine kinase inhibitors of the fraction of patients without a molecular response who continue targeted therapy with Tyrosine kinase inhibitors in first- and second- lines treatment of the chronic phase of CML. Variation of the fraction of the patients with ± 50% of the probabilities. The values are presented in Bulgarian monetary currency /Leva/.